C

Cell Signaling Technology

Antibody development and validated research tools

Product Marketing Manager - Biopharma, CRO & Custom Solutions

Full-TimeUpdated
$138k - $189k/yr+ 401(k) 6% match
Senior
Master's, PhD
Danvers, MA, USA
In Person
Growth & MarketingProduct Marketing

About the job

Requirements
  • Hands-on technical knowledge of antibody-based products and services, translated into clear messaging and sales tools.
  • Strong project management skills across multiple campaigns and launches at once.
  • A data-driven approach to measuring and improving marketing performance.
  • Excellent communication and presentation skills, including simplifying complex scientific and commercial concepts for diverse audiences.
  • A commitment to quality and continuous improvement.
  • A Master's or PhD in life sciences, such as molecular biology or biochemistry, or a related field.
  • At least 5 years of product marketing or related experience in the life sciences industry.
  • Direct BioPharma or CRO experience, such as working at, selling to, or partnering closely with BioPharma/CRO organizations.
  • Hands-on experience with antibody-based products or related life science tools.
  • Experience working with global sales channels and distributors.
  • Ability to build strong cross-functional relationships.
Responsibilities
  • Develop positioning and messaging for the reagent portfolio and custom services to address BioPharma and CRO buyers' workflows and priorities.
  • Build segment-specific value propositions that account for regulatory context, quality expectations, and procurement models.
  • Help set launch-success metrics, including adoption, customer feedback, and sales performance.
  • Plan and run campaigns to drive adoption of the portfolio and custom services among BioPharma and CRO buyers.
  • Work with MarComm and Channel Owners to create web, collateral, whitepaper, webinar, case study, and blog content that communicates portfolio value to this segment.
  • Work with regional marketing teams to localize campaigns for market-specific needs.
  • Bring voice-of-customer feedback into campaign plans to keep messaging relevant.
  • Build and deliver sales and distributor training, tools, objection-handling guides, and competitive guides to help commercial teams position the portfolio and custom services.
  • Align marketing activity and sales strategy to improve lead generation, pipeline speed, and revenue growth.
  • Support distributor platforms with targeted resources and programs.
  • Support the Associate Director and Custom Solutions Lead in commercializing custom and customized services, including input on service packaging, pricing, and tiered service models.
  • Contribute market opportunity assessments and revenue projections to business cases for new portfolio additions and custom capabilities.
  • Work with Operations and Product Management to ensure product supply, service capacity, and delivery standards align with customer communications.
  • Conduct ongoing research, including voice-of-customer interviews, surveys, and competitive analysis, on BioPharma and CRO needs and trends.
  • Build and maintain relationships with BioPharma and CRO customers and key opinion leaders to test messaging and gather field intelligence, sharing emerging needs with the Associate Director.
  • Track campaign and product performance with MarComm and Channel Owners, and report results and insights to leadership.
Desired Qualifications
  • Experience managing a reagent product line or a service portfolio, such as custom or contract services.
  • Familiarity with Pragmatic or similar marketing frameworks.

About the company

C

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Get referred to Cell Signaling Technology

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 2026 ISO 13485 certification widens CST's regulated manufacturing addressable market.
  • June 2026 Quantum-Si partnership ties CST to next-generation proteomics validation.
  • 2026 deals with Leveragen, MJFF, and Nordic Biosite expand distribution and disease-specific demand.

What critics are saying

  • Antibody catalogs commoditize fast; Thermo Fisher and Abcam pressure CST pricing by 2027.
  • WuXi Diagnostics partnership concentrates diagnostic ambitions inside one CDx channel and regulatory bottleneck.
  • A prolonged research funding slump would choke orders and expose CST's existential dependence on academia.

What makes Cell Signaling Technology unique

  • Scientists still own CST, preserving assay credibility and product discipline.
  • ISO 13485 certification covers Beverly and Leiden, strengthening regulated reagent manufacturing.
  • SignalStar and proprietary antibody platforms keep CST embedded across spatial biology workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Company Match
  • Tuition Reimbursement
  • Unlimited Paid Time Off
  • Parental Leave
  • Employee Assistance Program
  • Professional Development Budget

Growth & Insights and Company News

6 month growth

28%

1 year growth

28%

2 year growth

28%
Nordic Biosite
Aug 19th, 2026
Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies.

Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies. news August 19 2026 Nordic Biosite is excited to announce its exclusive distribution partnership across Sweden, Denmark, Norway, and Finland for Cell Signaling Technology's (CST) premier line of Pre-GMP-grade G4S Linker antibodies. Chimeric Antigen Receptor (CAR) cell therapy is moving at a rapid pace, but researchers often struggle with reliable tracking reagents during early-phase development. This exclusive partnership changes that by bringing CST's premier translational tools directly to the Nordic region. Nordic Biosite is fully authorized to distribute the following early-access, Pre-GMP-grade products: * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) By keeping these high-demand reagents in local stock, Nordic Biosite eliminates long international shipping delays, ensuring your lab has immediate access to the exact tools you need to advance your cell therapy research. News & articles. News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026 News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.